Italian biotech Cassiopea has won US approval for Winlevi, a topical therapy it says is the first new approach to treating acne in nearly 40 years. An androgen receptor inhibitor, Winlevi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback